FDA Approves First and Only Weekly Diabetes 2 Shot Therapy in the US

January 29, 2012
64 Views

Bydureon took three tries to make it through approval with the FDA.  The active ingredient comes from a synthetic version of saliva from the Gila Monster.  I am imageBydureon took three tries to make it through approval with the FDA.  The active ingredient comes from a synthetic version of saliva from the Gila Monster.  I am imageoriginally from Arizona and I know what those are and way back in 2007 the talk was in the exploration of saliva with lizards.  Bydureon is not insulin and is not for people with diabetes type 1.  Byetta is the non extended version of the drug that has been around for a once a day injection and has been associated with acute pancreatitis, so I would guess the same warnings would apply here as well. 

Lizard spit and bongs – Medication Origins and Future

BYDUREON has been approved with a Risk Evaluation and Mitigation Strategy (REMS) and there are a number of post market requirements to assess the impact of the drug relative to thyroid cancer or heart disease as some rats in the testing phase had those issues. 

Jan. 27 (Bloomberg) — Amylin Pharmaceuticals Inc. and Alkermes Plc succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin’s diabetes shot.

The Food and Drug Administration approved the drug for adults with Type 2 diabetes, the agency said today in a letter posted on their website.

Bydureon is a long-acting form of Byetta, a twice-daily injection that San Diego-based Amylin developed with Eli Lilly & Co. in a partnership that ended last year. Amylin lost almost half its market value on Oct. 20, 2010, after the FDA rejected Bydureon for a second time and sought a study on cardiac effects. The companies refiled for approval last year after the trial didn’t tie the drug to dangerous heart-rhythm changes.image

The active ingredient in Byetta and Bydureon, known as exenatide, stimulates pancreas cells to produce insulin when blood sugar is high. It is a synthetic version of a substance found in the saliva of the Gila monster. Bydureon uses technology developed by Alkermes to slowly release exenatide into the bloodstream with one dose a week. The drug won European Commission approval in June.

http://www.businessweek.com/news/2012-01-28/amylin-alkermes-diabetes-drug-wins-approval-on-third-try.html

 

You may be interested

What to Look for in Patient Solutions Software
eHealth
365 views
eHealth
365 views

What to Look for in Patient Solutions Software

Robert Cordray - August 17, 2017

The medical sector is one area where technology has had a significant impact, largely by providing tools that simplify many…

Can Natural Remedies Like RediCalm Decrease Stress and Anxiety?
Wellness
2 views
Wellness
2 views

Can Natural Remedies Like RediCalm Decrease Stress and Anxiety?

Ryan Kh - August 16, 2017

According to research from the National Institute of Mental Health, anxiety disorders are the most common mental illness in the…

How to Alleviate Stress Related Insomnia
Specialties
400 views
Specialties
400 views

How to Alleviate Stress Related Insomnia

JohnHenning - August 15, 2017

Do you have difficulty falling asleep or staying asleep every night? You aren't alone. According to multiple studies, including one…